-+ 0.00%
-+ 0.00%
-+ 0.00%

Biogen Moves Alzheimer's Drug to Late-Stage Trials. Wall Street Thinks It's a Mistake.

Barron‘s·05/14/2026 18:30:00

Please log in to view news